Efficacy and Safety of Modified Huang-Lian-Jie-Du Decoction Cream on Cancer Patients with Skin Side Effects Caused by EGFR Inhibition
(1) Background: The epidermal growth factor inhibitors (EGFRIs)/tyrosine kinase inhibitors (TKIs) are effective for cancer target therapy, but acneiform rashes or so-called inflammatory papulopustular exanthemas are common (50% to 90%). The conventional therapy for EGFRIs/TKIs-induced skin toxicity...
Main Authors: | Ming-Yang Lee, Mei-Yi Lin, Yu-Ju Chang, Yu-Ting Tseng, I-An Huang, Wan-Ting Huang, Yi-Wen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Processes |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9717/9/7/1081 |
Similar Items
-
Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts
by: De Tursi M, et al.
Published: (2017-06-01) -
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013
by: Siu-Fun Wong, et al.
Published: (2020-07-01) -
Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations
by: Yiyu Qi, et al.
Published: (2019-12-01) -
Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke
by: Pengqian Wang, et al.
Published: (2019-11-01) -
A new rapid titration protocol for lamotrigine that reduces the risk of skin rash
by: Yoonhyuk Jang, et al.
Published: (2021-06-01)